Form D · Biotechnology
Gold Standard Diagnostics Corp.
Davis, CA · CIK 0001491777
Offering snapshot reported Feb 11, 2013 · SEC filing
- Reported sold
- $1.01M Offering amount: $2M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 14, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 11, 2013 | Initial | $1,009,479 | No comparison | 4 | SEC filing |
| Aug 25, 2011 | Initial | $750,000 | No comparison | 5 | SEC filing |
| May 12, 2010 | Initial | $775,725 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 05
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-191602
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Feb 11, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Griffiths | Director, Executive |
| Roger Salquist | Director, Executive |
| Lorne F. Silverstein | Executive |
| James E. Thompson | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2851 Spafford Street Suite A
Davis, CA, 95618
Davis, CA, 95618